|
Total properties:
23
|
|
|
|
Patent #:
|
|
Issue Dt:
|
11/03/1998
|
Application #:
|
08538301
|
Filing Dt:
|
10/02/1995
|
|
Title:
|
TREATMENT OF VASCULAR INJURY USING VASCULAR ENDOTHELIAL GROWTH FACTOR
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
09/19/2000
|
Application #:
|
08545998
|
Filing Dt:
|
10/20/1995
|
|
Title:
|
METHOD FOR TREATING ISCHEMIC TISSUE
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
07/29/1997
|
Application #:
|
08675523
|
Filing Dt:
|
07/03/1996
|
|
Title:
|
METHODS AND PRODUCTS FOR NUCLEIC ACID DELIVERY
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
11/09/1999
|
Application #:
|
08744882
|
Filing Dt:
|
11/08/1996
|
|
Title:
|
METHODS FOR ENHANCING ANGIOGENESIS WITH ENDOTHELIAL PROGENITOR CELLS.
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
01/12/1999
|
Application #:
|
08810453
|
Filing Dt:
|
03/04/1997
|
|
Title:
|
FAS LIGAND COMPOSITIONS FOR TREATMENT OF PROLIFERATIVE DISORDERS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
07/10/2001
|
Application #:
|
08910539
|
Filing Dt:
|
07/30/1997
|
|
Title:
|
TREATMENT OF VASCULAR INJURY
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
11/23/1999
|
Application #:
|
08927394
|
Filing Dt:
|
08/27/1997
|
|
Title:
|
GATA-6 TRANSCRIPTION FACTOR: COMPOSITIONS AND METHODS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
10/17/2000
|
Application #:
|
09086498
|
Filing Dt:
|
05/22/1998
|
|
Title:
|
ANGIOGENESIS USING HEPATOCYTE GROWTH FACTOR
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
05/16/2000
|
Application #:
|
09185562
|
Filing Dt:
|
11/04/1998
|
|
Title:
|
METHOD FOR TREATING HYPERTENSION
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
01/04/2000
|
Application #:
|
09187466
|
Filing Dt:
|
11/04/1998
|
|
Title:
|
METHOD FOR TREATING DEPRESSION, OBSESSIVE COMPULSIVE DISORDER, AND ANXIETY WITH N-ACETYL SEROTONIN
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
04/09/2002
|
Application #:
|
09204254
|
Filing Dt:
|
12/03/1998
|
|
Title:
|
HIGH EFFICIENCY LOCAL DRUG DELIVERY
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
05/27/2003
|
Application #:
|
09228020
|
Filing Dt:
|
01/11/1999
|
|
Title:
|
METHODS FOR REGULATING ANGIOGENESIS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
01/13/2004
|
Application #:
|
09265041
|
Filing Dt:
|
03/09/1999
|
|
Title:
|
COMPOSITIONS AND METHODS FOR MODULATING VASCULARIZATION
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
05/06/2008
|
Application #:
|
09408905
|
Filing Dt:
|
09/29/1999
|
|
Title:
|
AKT COMPOSITIONS FOR ENHANCING SURVIVAL OF CELLS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
10/24/2006
|
Application #:
|
09546733
|
Filing Dt:
|
04/11/2000
|
|
Title:
|
ANGIOGENIC GROWTH FACTORS FOR TREATMENT OF PERIPHERAL NEUROPATHY
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
05/29/2001
|
Application #:
|
09559609
|
Filing Dt:
|
04/27/2000
|
|
Title:
|
Method for treating depression
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
02/10/2004
|
Application #:
|
09590740
|
Filing Dt:
|
06/08/2000
|
|
Title:
|
HMG COA REDUCTASE INHIBITORS FOR PROMOTING ANGIOGENESIS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
03/05/2002
|
Application #:
|
09673451
|
Filing Dt:
|
03/23/2001
|
|
Title:
|
Method for treating neurodegenerative disorders
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
05/13/2003
|
Application #:
|
09834041
|
Filing Dt:
|
04/12/2001
|
|
Publication #:
|
|
Pub Dt:
|
11/29/2001
| | | | |
|
Title:
|
METHOD FOR TREATING DEPRESSION
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
02/01/2005
|
Application #:
|
10390967
|
Filing Dt:
|
03/18/2003
|
|
Publication #:
|
|
Pub Dt:
|
09/18/2003
| | | | |
|
Title:
|
5-Methoxy-Carbonylamino-N-Acetyltrytamine Compounds and Derivatives Thereof
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
10/17/2006
|
Application #:
|
10436548
|
Filing Dt:
|
05/12/2003
|
|
Publication #:
|
|
Pub Dt:
|
11/18/2004
| | | | |
|
Title:
|
METHODS OF AND SYSTEMS AND DEVICES FOR ASSESSING INTRACRANIAL PRESSURE NON-INVASIVELY
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
12/29/2009
|
Application #:
|
11582872
|
Filing Dt:
|
10/18/2006
|
|
Publication #:
|
|
Pub Dt:
|
05/03/2007
| | | | |
|
Title:
|
GENERATION AND USE OF VASCULOGENIC TUMORS AND PRODUCTS DERIVED FROM SAME
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
04/27/2010
|
Application #:
|
11800113
|
Filing Dt:
|
05/03/2007
|
|
Publication #:
|
|
Pub Dt:
|
03/06/2008
| | | | |
|
Title:
|
REVERSIBLE INHIBITION OF PYRAMIDAL GAP JUNCTION ACTIVITY
|
|
